Management of arrhythmias in heart failure. What a practicing physician should know in the current times

Rajesh Ramineni, Mani Kumar Bheemarasetti, Adrian Baranchuk, Tapasya Mandalapu, Venkat K. Mukku, Kenichi Fujise, Alejandro Barbagelata

Research output: Contribution to journalArticle

Abstract

Arrhythmias play a significant role in the mortality and morbidity as well as hospitalizations of patients who carry a diagnosis of congestive heart failure. With improving survival in a world of novel medications and devices, an understanding of the pathophysiology and management of these arrhythmias is crucial. Majority of the basic heart failure medications such as beta-blockers, angiotensin converting enzyme inhibitors/aldosterone receptor blockers and aldosterone antagonists play a pivotal role in prevention of sudden cardiac deaths which can be a direct/indirect result of these arrhythmias. Anti-arrhythmic drugs and implantable cardioverter-defibrillators were also beneficial in selected patients. Innovative electrophysiological techniques need to be considered in special situations.

Original languageEnglish (US)
Pages (from-to)567-577
Number of pages11
JournalCardiology Journal
Volume19
Issue number6
DOIs
StatePublished - 2012

Fingerprint

Mineralocorticoid Receptor Antagonists
Cardiac Arrhythmias
Heart Failure
Physicians
Implantable Defibrillators
Anti-Arrhythmia Agents
Sudden Cardiac Death
Angiotensin-Converting Enzyme Inhibitors
Hospitalization
Morbidity
Equipment and Supplies
Survival
Mortality
Pharmaceutical Preparations

Keywords

  • Arrhythmias
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ramineni, R., Bheemarasetti, M. K., Baranchuk, A., Mandalapu, T., Mukku, V. K., Fujise, K., & Barbagelata, A. (2012). Management of arrhythmias in heart failure. What a practicing physician should know in the current times. Cardiology Journal, 19(6), 567-577. https://doi.org/10.5603/CJ.2012.0107

Management of arrhythmias in heart failure. What a practicing physician should know in the current times. / Ramineni, Rajesh; Bheemarasetti, Mani Kumar; Baranchuk, Adrian; Mandalapu, Tapasya; Mukku, Venkat K.; Fujise, Kenichi; Barbagelata, Alejandro.

In: Cardiology Journal, Vol. 19, No. 6, 2012, p. 567-577.

Research output: Contribution to journalArticle

Ramineni, R, Bheemarasetti, MK, Baranchuk, A, Mandalapu, T, Mukku, VK, Fujise, K & Barbagelata, A 2012, 'Management of arrhythmias in heart failure. What a practicing physician should know in the current times', Cardiology Journal, vol. 19, no. 6, pp. 567-577. https://doi.org/10.5603/CJ.2012.0107
Ramineni, Rajesh ; Bheemarasetti, Mani Kumar ; Baranchuk, Adrian ; Mandalapu, Tapasya ; Mukku, Venkat K. ; Fujise, Kenichi ; Barbagelata, Alejandro. / Management of arrhythmias in heart failure. What a practicing physician should know in the current times. In: Cardiology Journal. 2012 ; Vol. 19, No. 6. pp. 567-577.
@article{dd55c571307048e89c53e45eeb0437e4,
title = "Management of arrhythmias in heart failure. What a practicing physician should know in the current times",
abstract = "Arrhythmias play a significant role in the mortality and morbidity as well as hospitalizations of patients who carry a diagnosis of congestive heart failure. With improving survival in a world of novel medications and devices, an understanding of the pathophysiology and management of these arrhythmias is crucial. Majority of the basic heart failure medications such as beta-blockers, angiotensin converting enzyme inhibitors/aldosterone receptor blockers and aldosterone antagonists play a pivotal role in prevention of sudden cardiac deaths which can be a direct/indirect result of these arrhythmias. Anti-arrhythmic drugs and implantable cardioverter-defibrillators were also beneficial in selected patients. Innovative electrophysiological techniques need to be considered in special situations.",
keywords = "Arrhythmias, Heart failure",
author = "Rajesh Ramineni and Bheemarasetti, {Mani Kumar} and Adrian Baranchuk and Tapasya Mandalapu and Mukku, {Venkat K.} and Kenichi Fujise and Alejandro Barbagelata",
year = "2012",
doi = "10.5603/CJ.2012.0107",
language = "English (US)",
volume = "19",
pages = "567--577",
journal = "Cardiology Journal",
issn = "1897-5593",
publisher = "Via Medica",
number = "6",

}

TY - JOUR

T1 - Management of arrhythmias in heart failure. What a practicing physician should know in the current times

AU - Ramineni, Rajesh

AU - Bheemarasetti, Mani Kumar

AU - Baranchuk, Adrian

AU - Mandalapu, Tapasya

AU - Mukku, Venkat K.

AU - Fujise, Kenichi

AU - Barbagelata, Alejandro

PY - 2012

Y1 - 2012

N2 - Arrhythmias play a significant role in the mortality and morbidity as well as hospitalizations of patients who carry a diagnosis of congestive heart failure. With improving survival in a world of novel medications and devices, an understanding of the pathophysiology and management of these arrhythmias is crucial. Majority of the basic heart failure medications such as beta-blockers, angiotensin converting enzyme inhibitors/aldosterone receptor blockers and aldosterone antagonists play a pivotal role in prevention of sudden cardiac deaths which can be a direct/indirect result of these arrhythmias. Anti-arrhythmic drugs and implantable cardioverter-defibrillators were also beneficial in selected patients. Innovative electrophysiological techniques need to be considered in special situations.

AB - Arrhythmias play a significant role in the mortality and morbidity as well as hospitalizations of patients who carry a diagnosis of congestive heart failure. With improving survival in a world of novel medications and devices, an understanding of the pathophysiology and management of these arrhythmias is crucial. Majority of the basic heart failure medications such as beta-blockers, angiotensin converting enzyme inhibitors/aldosterone receptor blockers and aldosterone antagonists play a pivotal role in prevention of sudden cardiac deaths which can be a direct/indirect result of these arrhythmias. Anti-arrhythmic drugs and implantable cardioverter-defibrillators were also beneficial in selected patients. Innovative electrophysiological techniques need to be considered in special situations.

KW - Arrhythmias

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=84873636855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873636855&partnerID=8YFLogxK

U2 - 10.5603/CJ.2012.0107

DO - 10.5603/CJ.2012.0107

M3 - Article

C2 - 23224918

AN - SCOPUS:84873636855

VL - 19

SP - 567

EP - 577

JO - Cardiology Journal

JF - Cardiology Journal

SN - 1897-5593

IS - 6

ER -